Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,311 | -6,667 | -27,698 | -11,100 | -6,548 |
| Depreciation Amortization | 339 | 170 | 678 | 508 | 339 |
| Accounts payable and accrued liabilities | 131 | 376 | 105 | -41 | -179 |
| Other Working Capital | 304 | 322 | 2 | -14 | -190 |
| Other Operating Activity | 269 | 2,949 | 17,021 | 2,940 | 1,633 |
| Operating Cash Flow | $-6,268 | $-2,851 | $-9,893 | $-7,708 | $-4,945 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -7 | -7 | N/A |
| Investing Cash Flow | $N/A | $N/A | $-7 | $-7 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,698 | 3,803 | 21,853 | 12,225 | 5,839 |
| Dividend Paid | N/A | N/A | -29 | -29 | -29 |
| Other Financing Activity | 0 | 0 | 2,550 | 2,550 | 2,550 |
| Financing Cash Flow | $8,698 | $3,803 | $24,374 | $14,746 | $8,360 |
| Beginning Cash Position | 15,696 | 15,696 | 1,222 | 1,222 | 1,222 |
| End Cash Position | 18,126 | 16,649 | 15,696 | 8,254 | 4,636 |
| Net Cash Flow | $2,430 | $953 | $14,475 | $7,032 | $3,414 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,268 | -2,851 | -9,893 | -7,708 | -4,945 |
| Capital Expenditure | N/A | N/A | -7 | -7 | N/A |
| Free Cash Flow | -6,268 | -2,851 | -9,899 | -7,714 | -4,945 |